Financial results - PHARMA BIOS S.R.L.

Financial Summary - Pharma Bios S.r.l.
Unique identification code: 3278720
Registration number: J34/1593/1992
Nace: 4773
Sales - Ron
28.507
Net Profit - Ron
6.126
Employees
1
Open Account
Company Pharma Bios S.r.l. with Fiscal Code 3278720 recorded a turnover of 2024 of 28.507, with a net profit of 6.126 and having an average number of employees of 1. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharma Bios S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 105.582 64.670 13.827 8.330 13.831 22.525 25.796 27.617 28.335 28.507
Total Income - EUR 138.571 67.177 13.827 8.330 13.831 22.525 26.474 27.617 47.022 34.217
Total Expenses - EUR 135.722 66.115 17.522 11.713 14.847 16.822 23.315 23.423 26.327 27.800
Gross Profit/Loss - EUR 2.849 1.063 -3.695 -3.383 -1.015 5.703 3.158 4.193 20.695 6.417
Net Profit/Loss - EUR 2.849 1.063 -4.047 -3.633 -1.430 5.049 2.364 3.365 17.816 6.126
Employees 2 1 0 0 0 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 1.2%, from 28.335 euro in the year 2023, to 28.507 euro in 2024. The Net Profit decreased by -11.590 euro, from 17.816 euro in 2023, to 6.126 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharma Bios S.r.l.

Rating financiar

Financial Rating -
PHARMA BIOS S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharma Bios S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharma Bios S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharma Bios S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharma Bios S.r.l. - CUI 3278720

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 14.378 15.413 14.835 14.252 13.671 13.212 12.919 12.960 9.203 9.152
Current Assets 105.359 45.194 36.981 27.427 24.998 17.201 19.848 11.616 36.711 25.045
Inventories 76.284 33.212 20.212 9.544 6.300 4.275 10.430 3.338 16.544 8.436
Receivables 17.590 11.098 16.066 16.910 16.625 8.924 3.638 2.966 4.924 9.794
Cash 11.485 885 703 973 2.073 4.002 5.781 5.312 15.243 6.815
Shareholders Funds -4.280 -3.174 -7.167 -10.669 -11.892 -8.060 -5.518 -2.170 15.652 7.706
Social Capital 47 47 46 45 44 43 42 43 42 42
Debts 124.017 63.781 58.983 52.347 50.562 38.474 38.285 26.745 30.262 26.491
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 25.045 euro in 2024 which includes Inventories of 8.436 euro, Receivables of 9.794 euro and cash availability of 6.815 euro.
The company's Equity was valued at 7.706 euro, while total Liabilities amounted to 26.491 euro. Equity decreased by -7.859 euro, from 15.652 euro in 2023, to 7.706 in 2024.

Risk Reports Prices

Reviews - Pharma Bios S.r.l.

Comments - Pharma Bios S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.